Is Moderna Stock Really Headed to $112?
Wall Street analysts are cranking up their price targets on the biotech in response to early clinical trial results for its coronavirus vaccine candidate.
Full Article
Is Moderna Stock Really Headed to $112?
Motley Fool
0 shares
1 views
You might like
Related news coverage
Better Coronavirus Stock: Moderna or Inovio Pharmaceuticals?
Motley Fool
The coronavirus vaccine race offers these clinical stage companies an opportunity to bring a first product to market -- if all goes..
-
Are Moderna’s Coronavirus Gains Over?
Motley Fool
-
Why Moderna Stock Jumped 10.7% Today
Motley Fool
-
Why Moderna Stock Rose Today
Motley Fool
-
MRNA Moderna using unethical and untested animal and human genes in vaccine - social media bans info
NaturalNews.com
Advertisement
More coverage
Moderna falls 20% amid reports that insiders have sold $89 million in shares this year as the stock has spiked (MRNA)
Business Insider
· *Moderna dropped as much as 20% on Wednesday amid a report from Stat News that insiders at the biotech company have liquidated..
-
Race for coronavirus vaccines stokes a biotech stock bubble
CBS News
-
Coronavirus vaccine czar reluctantly decides to forego windfall stock profits after earlier claiming "no conflict of interest"
NaturalNews.com
-
Why Moderna Stock Dropped Today
Motley Fool
-
Why Arcturus Therapeutics Stock Is Plunging Today
Motley Fool